{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:06:05Z","timestamp":1791921965411,"version":"4.3.4"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-02104-w","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T20:21:12Z","timestamp":1747340472000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Coagulation profiles of breast cancer patients attending at cancer treatment centres in Northwest Ethiopia 2023: a comparative cross-sectional study"],"prefix":"10.1038","volume":"15","author":[{"given":"Sisay","family":"Ayana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melak","family":"Aynalem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiruneh","family":"Adane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Shiferaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"issue":"1","key":"2104_CR1","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41598-023-28139-5","volume":"13","author":"H Debash","year":"2023","unstructured":"Debash, H., Bisetegn, H., Nigatie, M., Abeje, G. & Feleke, D. G. Epidemiological, clinical and hematological profiles of visceral leishmaniasis among patients visiting Tefera Hailu Memorial Hospital, Northeast Ethiopia: A 4 year retrospective study. Sci. Rep. 13(1), 931 (2023).","journal-title":"Sci. Rep."},{"key":"2104_CR2","unstructured":"Organization WH. Breast Cancer Awareness Month 2021: IARC. www.iarc.who.int. https:\/\/www.iarc.who.int\/featured-news\/breast-cancer-awareness-month-2021\/. Accessed July 2023."},{"key":"2104_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold, M. et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. The Breast. 66, 15\u201323 (2022).","journal-title":"The Breast."},{"issue":"1","key":"2104_CR4","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12905-024-03133-9","volume":"24","author":"A Zewdie","year":"2024","unstructured":"Zewdie, A. et al. Advanced-stage breast cancer diagnosis and its determinants in Ethiopia: A systematic review and meta-analysis. BMC Womens Health 24(1), 284 (2024).","journal-title":"BMC Womens Health"},{"issue":"10","key":"2104_CR5","doi-asserted-by":"publisher","first-page":"e0275171","DOI":"10.1371\/journal.pone.0275171","volume":"17","author":"T Demeke","year":"2022","unstructured":"Demeke, T. et al. Health system cost of breast cancer treatment in Addis Ababa, Ethiopia. PLoS ONE 17(10), e0275171 (2022).","journal-title":"PLoS ONE"},{"issue":"1","key":"2104_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/tropicalmed8010036","volume":"8","author":"M Ademe","year":"2023","unstructured":"Ademe, M. et al. Hematological and clinical features associated with initial poor treatment outcomes in visceral leishmaniasis patients with and without HIV coinfection in Gondar, northwest Ethiopia. Trop. Med. Infect. Dis. 8(1), 36 (2023).","journal-title":"Trop. Med. Infect. Dis."},{"issue":"8","key":"2104_CR7","doi-asserted-by":"publisher","first-page":"e0009632","DOI":"10.1371\/journal.pntd.0009632","volume":"15","author":"D Tadesse","year":"2021","unstructured":"Tadesse, D., Abdissa, A., Mekonnen, M., Belay, T. & Hailu, A. Antibody and cytokine levels in visceral leishmaniasis patients with varied parasitemia before, during, and after treatment in patients admitted to Arba Minch General Hospital, southern Ethiopia. PLoS Neglect. Trop. Dis. 15(8), e0009632 (2021).","journal-title":"PLoS Neglect. Trop. Dis."},{"key":"2104_CR8","volume-title":"Clinical Manifestations and Anthropometric Profiles of Visceral Leishmaniasis in Selected Centres in Ethiopia","author":"AM Beshah","year":"2011","unstructured":"Beshah, A. M. Clinical Manifestations and Anthropometric Profiles of Visceral Leishmaniasis in Selected Centres in Ethiopia (University of South Africa, 2011)."},{"issue":"2","key":"2104_CR9","first-page":"485","volume":"29","author":"AM Nail","year":"2013","unstructured":"Nail, A. M. & Imam, A. M. Visceral leishmaniasis: Clinical and demographic features in an African population. Pakist. J. Med. Sci. 29(2), 485 (2013).","journal-title":"Pakist. J. Med. Sci."},{"issue":"4","key":"2104_CR10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.mpmed.2017.01.013","volume":"45","author":"SK Austin","year":"2017","unstructured":"Austin, S. K. Haemostasis. Medicine 45(4), 204\u2013208 (2017).","journal-title":"Medicine"},{"key":"2104_CR11","first-page":"1","volume":"II","author":"J Arnout","year":"2006","unstructured":"Arnout, J., Hoylaerts, M. & Lijnen, H. Haemostasis. Vasc. Endothel. II, 1\u201341 (2006).","journal-title":"Vasc. Endothel."},{"issue":"09","key":"2104_CR12","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1055\/s-0037-1616139","volume":"86","author":"S Sallah","year":"2001","unstructured":"Sallah, S., Wan, J. Y., Nguyen, N. P., Hanrahan, L. & Sigounas, G. Disseminated intravascular coagulation in solid tumors: Clinical and pathologic study. Thromb. Haemost. 86(09), 828\u2013833 (2001).","journal-title":"Thromb. Haemost."},{"issue":"15","key":"2104_CR13","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.4103\/0366-6999.186637","volume":"129","author":"Y-W Zhu","year":"2016","unstructured":"Zhu, Y.-W. et al. Routine hemostasis and hemogram parameters: Valuable assessments for coagulation disorder and chemotherapy in cancer patients. Chin. Med. J. 129(15), 1772\u20131777 (2016).","journal-title":"Chin. Med. J."},{"key":"2104_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-018-1511-x","volume":"16","author":"C Mandoj","year":"2018","unstructured":"Mandoj, C. et al. Observational study of coagulation activation in early breast cancer: Development of a prognostic model based on data from the real world setting. J. Transl. Med. 16, 1\u20139 (2018).","journal-title":"J. Transl. Med."},{"issue":"12","key":"2104_CR15","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1111\/jth.15880","volume":"20","author":"F Moik","year":"2022","unstructured":"Moik, F. & Ay, C. Hemostasis and cancer: Impact of haemostatic biomarkers for the prediction of clinical outcomes in patients with cancer. J. Thromb. Haemost. 20(12), 2733\u20132745 (2022).","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"2104_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.11648\/j.ijhpebs.20170305.11","volume":"3","author":"E Tesfaye","year":"2017","unstructured":"Tesfaye, E., Fissehatsion, K., Terefe, B. & Enawgaw, B. Haematological abnormalities in visceral leishmaniasis patients attending Gondar University Hospital; retrospective study. Int. J. HIV AIDS Prev. Educ. Behav. Sci. 3(5), 48\u201353 (2017).","journal-title":"Int. J. HIV AIDS Prev. Educ. Behav. Sci."},{"key":"2104_CR17","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20130057","author":"LG Lima","year":"2013","unstructured":"Lima, L. G. & Monteiro, R. Q. Activation of blood coagulation in cancer: implications for tumour progression. Biosci. Rep. https:\/\/doi.org\/10.1042\/BSR20130057 (2013)."},{"issue":"7","key":"2104_CR18","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/sj.bjc.6604620","volume":"99","author":"CC Kirwan","year":"2008","unstructured":"Kirwan, C. C., McDowell, G., McCollum, C. N., Kumar, S. & Byrne, G. J. Early changes in the haemostatic and procoagulant systems after chemotherapy for breast cancer. Br. J. Cancer 99(7), 1000\u20131006 (2008).","journal-title":"Br. J. Cancer"},{"issue":"5","key":"2104_CR19","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3390\/life13051106","volume":"13","author":"K Wrzeszcz","year":"2023","unstructured":"Wrzeszcz, K., Rhone, P., Kwiatkowska, K. & Ruszkowska-Ciastek, B. Hypercoagulability state combined with post-treatment hypofibrinolysis in invasive breast cancer: A 7-year follow-up evaluating disease-free and overall survival. Life 13(5), 1106 (2023).","journal-title":"Life"},{"issue":"6","key":"2104_CR20","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/sj.neo.7900263","volume":"4","author":"GJ Caine","year":"2002","unstructured":"Caine, G. J., Stonelake, P. S., Lip, G. Y. & Kehoe, S. T. The hypercoagulable state of malignancy: Pathogenesis and current debate. Neoplasia 4(6), 465\u2013473 (2002).","journal-title":"Neoplasia"},{"issue":"2","key":"2104_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrc3004","volume":"11","author":"LJ Gay","year":"2011","unstructured":"Gay, L. J. & Felding-Habermann, B. Contribution of platelets to tumour metastasis. Nat. Rev. Cancer 11(2), 123\u2013134 (2011).","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"2104_CR22","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1538-7836.2010.04131.x","volume":"9","author":"N Bambace","year":"2011","unstructured":"Bambace, N. & Holmes, C. The platelet contribution to cancer progression. J. Thromb. Haemost. 9(2), 237\u2013249 (2011).","journal-title":"J. Thromb. Haemost."},{"key":"2104_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/bcr3425","volume":"15","author":"I Lal","year":"2013","unstructured":"Lal, I., Dittus, K. & Holmes, C. E. Platelets, coagulation and fibrinolysis in breast cancer progression. Breast Cancer Res. 15, 1\u201311 (2013).","journal-title":"Breast Cancer Res."},{"issue":"2","key":"2104_CR24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/sj.bjp.0705606","volume":"141","author":"D Alonso-Escolano","year":"2004","unstructured":"Alonso-Escolano, D., Strongin, A. Y., Chung, A. W., Deryugina, E. I. & Radomski, M. W. Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins. Br. J. Pharmacol. 141(2), 241 (2004).","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"2104_CR25","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s10549-021-06484-1","volume":"192","author":"LY Dirix","year":"2022","unstructured":"Dirix, L. Y. et al. Coagulation\/fibrinolysis and circulating tumor cells in patients with advanced breast cancer. Breast Cancer Res. Treat. 192(3), 583\u2013591 (2022).","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"2104_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.21037\/apm.2017.11.01","volume":"7","author":"C Johnstone","year":"2018","unstructured":"Johnstone, C. & Rich, S. E. Bleeding in cancer patients and its treatment: a review. Ann. Palliat. Med. 7(2), 265\u2013273 (2018).","journal-title":"Ann. Palliat. Med."},{"issue":"2","key":"2104_CR27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0889-8588(05)70347-6","volume":"10","author":"KE Goad","year":"1996","unstructured":"Goad, K. E. & Gralnick, H. R. Coagulation disorders in cancer. Hematol.\/Oncol. Clin. 10(2), 457\u2013484 (1996).","journal-title":"Hematol.\/Oncol. Clin."},{"issue":"8","key":"2104_CR28","doi-asserted-by":"publisher","first-page":"e0271895","DOI":"10.1371\/journal.pone.0271895","volume":"17","author":"M Aynalem","year":"2022","unstructured":"Aynalem, M. et al. Hematological abnormalities before and after initiation of cancer treatment among breast cancer patients attending at the University of Gondar comprehensive specialized hospital cancer treatment center. PLoS ONE 17(8), e0271895 (2022).","journal-title":"PLoS ONE"},{"key":"2104_CR29","doi-asserted-by":"publisher","first-page":"205031212211316","DOI":"10.1177\/20503121221131691","volume":"10","author":"B Kefale","year":"2022","unstructured":"Kefale, B. et al. Clinical pattern and drug-related problems among colorectal cancer patients at oncology center in Ethiopia: A hospital-based study. SAGE Open Med. 10, 20503121221131692 (2022).","journal-title":"SAGE Open Med."},{"key":"2104_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fpain.2022.884253","author":"AA Kibret","year":"2022","unstructured":"Kibret, A. A. et al. Prevalence and associated factors of cancer pain among adult cancer patients evaluated at an oncology unit in the University of Gondar Comprehensive Specialized Hospital, northwest Ethiopia. Front. Pain Res. https:\/\/doi.org\/10.3389\/fpain.2022.884253 (2022).","journal-title":"Front. Pain Res."},{"issue":"2","key":"2104_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.20982\/tqmp.03.2.p043","volume":"3","author":"CW VanVoorhis","year":"2007","unstructured":"VanVoorhis, C. W. & Morgan, B. L. Understanding power and rules of thumb for determining sample sizes. Tutor. Quant. Methods Psychol. 3(2), 43\u201350 (2007).","journal-title":"Tutor. Quant. Methods Psychol."},{"key":"2104_CR32","unstructured":"Zaidi, S. R. H. & Rout, P. Interpretation of Blood Clotting Studies and Values (PT, PTT, aPTT, INR, Anti-Factor Xa, D-Dimer). StatPearls [Internet]: StatPearls Publishing (2024)."},{"issue":"7","key":"2104_CR33","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/tmi.13071","volume":"23","author":"B Enawgaw","year":"2018","unstructured":"Enawgaw, B. et al. Haematological and immunological reference intervals for adult population in the state of Amhara, Ethiopia. Trop. Med. Int. Health 23(7), 765\u2013773 (2018).","journal-title":"Trop. Med. Int. Health"},{"key":"2104_CR34","unstructured":"Organization WH. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations. www.who.int. https:\/\/www.who.int\/publications\/i\/item\/9789240000124. Accessed July 2023."},{"key":"2104_CR35","unstructured":"H21A5: Plasma-Based Coagulation & Hemostasis Assay Test. Clinical & Laboratory Standards Institute. https:\/\/clsi.org\/standards\/products\/hematology\/documents\/h21\/."},{"key":"2104_CR36","unstructured":"SYSMEX KX-21 OPERATOR\u2019S MANUAL Pdf Download. ManualsLib. 2023 [cited 2023 Nov 12]. https:\/\/www.manualslib.com\/manual\/2978468\/Sysmex-Kx-21.html."},{"key":"2104_CR37","unstructured":"Model. Genrui CA52 Screen Semi-Automatic Coagulation Analyser. Medical XPRT. 2023. https:\/\/www.medical-xprt.com\/products\/genrui-model-ca52-screen-semi-automatic-coagulation-analyser-857452."},{"key":"2104_CR38","unstructured":"Research Guidelines: University of Gondar Official Website. University of Gondar Official Website\u2014University of Gondar Official Website. 2022. https:\/\/uog.edu.et\/research-guidelines\/. Accessed 12 Nov 2023."},{"key":"2104_CR39","doi-asserted-by":"publisher","first-page":"5985","DOI":"10.1007\/s13277-014-1793-4","volume":"35","author":"F Tas","year":"2014","unstructured":"Tas, F., Kilic, L. & Duranyildiz, D. Coagulation tests show significant differences in patients with breast cancer. Tumor Biol. 35, 5985\u20135992 (2014).","journal-title":"Tumor Biol."},{"key":"2104_CR40","unstructured":"Disseminated Intravascular Coagulation (DIC). Merck Manual Professional Edition; Merck Manuals. https:\/\/www.merckmanuals.com\/professional\/hematology-and-oncology\/coagulation-disorders\/disseminated-intravascular-coagulation-dic?utm_source=chatgpt.com. Streiff, M. B. (2023, September 5)."},{"issue":"1","key":"2104_CR41","doi-asserted-by":"publisher","first-page":"001","DOI":"10.29328\/journal.jhcr.1001015","volume":"5","author":"G Khichariya","year":"2021","unstructured":"Khichariya, G., Manjula, K., Das, S. & Kalyani, R. A study of coagulation profile in patients with cancer in a tertiary care hospital. J. Hematol. Clin. Res. 5(1), 001\u2013003 (2021).","journal-title":"J. Hematol. Clin. Res."},{"issue":"4497","key":"2104_CR42","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1126\/science.7195067","volume":"212","author":"HF Dvorak","year":"1981","unstructured":"Dvorak, H. F. et al. Tumor shedding and coagulation. Science 212(4497), 923\u2013924 (1981).","journal-title":"Science"},{"issue":"1","key":"2104_CR43","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/jth.13181","volume":"14","author":"JE Geddings","year":"2016","unstructured":"Geddings, J. E. et al. Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice. J. Thromb. Haemost. 14(1), 153\u2013166 (2016).","journal-title":"J. Thromb. Haemost."},{"key":"2104_CR44","unstructured":"National Comprehensive Cancer Network. NCCN Guidelines. https:\/\/www.nccn.org\/guidelines"},{"issue":"12","key":"2104_CR45","doi-asserted-by":"publisher","first-page":"e76481","DOI":"10.7759\/cureus.76481","volume":"16","author":"S Carpintieri","year":"2024","unstructured":"Carpintieri, S., Uyar, E., Anand, C. & Buryk, Y. Cancer history, antiphospholipid syndrome, and lupus anticoagulant: A perfect storm for thrombosis. Cureus 16(12), e76481. https:\/\/doi.org\/10.7759\/cureus.76481 (2024).","journal-title":"Cureus"},{"issue":"9","key":"2104_CR46","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1158\/2326-6066.CIR-17-0574","volume":"6","author":"H Zhang","year":"2018","unstructured":"Zhang, H. et al. Circulating tumor microparticles promote lung metastasis by reprogramming inflammatory and mechanical niches via a macrophage-dependent pathway. Cancer Immunol. Res. 6(9), 1046\u20131056 (2018).","journal-title":"Cancer Immunol. Res."},{"issue":"5","key":"2104_CR47","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3892\/mco.2015.584","volume":"3","author":"Z Wang","year":"2015","unstructured":"Wang, Z. et al. Cyclophosphamide, epirubicin and fluorouracil chemotherapy-induced alteration of haemostasis markers in breast cancer patients. Mol. Clin. Oncol. 3(5), 1088\u20131092 (2015).","journal-title":"Mol. Clin. Oncol."},{"issue":"2","key":"2104_CR48","first-page":"96","volume":"1","author":"T Ahmed","year":"2014","unstructured":"Ahmed, T. et al. Comparative study to access coagulation abnormalities in breast cancer. Adv. Life Sci. 1(2), 96\u2013103 (2014).","journal-title":"Adv. Life Sci."},{"issue":"2","key":"2104_CR49","doi-asserted-by":"publisher","first-page":"218","DOI":"10.21088\/nijs.0976.4747.9218.20","volume":"9","author":"BD Manjunath","year":"2018","unstructured":"Manjunath, B. D., Abhishek, G. & Prem Kumar, A. Coagulation abnormalities in breast cancer. N. Indian J. Surg. 9(2), 218\u2013223 (2018).","journal-title":"N. Indian J. Surg."},{"key":"2104_CR50","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/9781444306286.ch8","volume-title":"Practical Hemostasis and Thrombosis","author":"G Castaman","year":"2009","unstructured":"Castaman, G. et al. Practical Hemostasis and Thrombosis 73\u201387 (Blackwell, 2009)."},{"issue":"2","key":"2104_CR51","first-page":"120","volume":"9","author":"E Previtali","year":"2011","unstructured":"Previtali, E., Bucciarelli, P., Passamonti, S. M. & Martinelli, I. Risk factors for venous and arterial thrombosis. Blood Transfus. 9(2), 120 (2011).","journal-title":"Blood Transfus."},{"key":"2104_CR52","unstructured":"Vitamin K Deficiency. (2025). Cornell University College of Veterinary Medicine. https:\/\/www.vet.cornell.edu\/animal-health-diagnostic-center\/testing\/testing-protocols-interpretations\/vitamin-k-deficiency?utm_source=chatgpt.com."},{"key":"2104_CR53","unstructured":"Conferences. (2024, July 2). Cancer Therapy Advisor. https:\/\/www.cancertherapyadvisor.com\/conferences\/."},{"issue":"6","key":"2104_CR54","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1378\/chest.105.6.1639","volume":"105","author":"JR Sporn","year":"1994","unstructured":"Sporn, J. R. & Rickles, F. R. Coagulation abnormalities in cancer patients. Clin. Relevance Chest. 105(6), 1639. https:\/\/doi.org\/10.1378\/chest.105.6.1639 (1994).","journal-title":"Clin. Relevance Chest."},{"key":"2104_CR55","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41523-021-00367-w","volume":"7","author":"L Bian","year":"2021","unstructured":"Bian, L. et al. Survival benefit of platinum-based regimen in early stage triple negative breast cancer: A meta-analysis of randomized controlled trials. npj Breast Cancer 7, 157. https:\/\/doi.org\/10.1038\/s41523-021-00367-w (2021).","journal-title":"npj Breast Cancer"},{"issue":"3","key":"2104_CR56","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3350\/cmh.2014.20.3.317","volume":"20","author":"A Sharma","year":"2014","unstructured":"Sharma, A. et al. Chemotherapy induced liver abnormalities: An imaging perspective. Clin. Mol. Hepatol. 20(3), 317\u2013326. https:\/\/doi.org\/10.3350\/cmh.2014.20.3.317 (2014).","journal-title":"Clin. Mol. Hepatol."},{"key":"2104_CR57","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.thromres.2021.01.012","volume":"200","author":"MP Ward","year":"2021","unstructured":"Ward, M. P. et al. Procoagulant activity in high grade serous ovarian cancer patients following neoadjuvant chemotherapy-the role of the activated protein C pathway. Thromb. Res. 200, 91\u201398 (2021).","journal-title":"Thromb. Res."},{"issue":"2","key":"2104_CR58","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BF01806210","volume":"40","author":"C Rella","year":"1996","unstructured":"Rella, C. et al. A prothrombotic state in breast cancer patients treated with adjuvant chemotherapy. Breast Cancer Res. Treat. 40(2), 151\u2013159. https:\/\/doi.org\/10.1007\/BF01806210 (1996).","journal-title":"Breast Cancer Res. Treat."},{"issue":"11","key":"2104_CR59","doi-asserted-by":"publisher","first-page":"665534","DOI":"10.3389\/fonc.2021.665534","volume":"12","author":"A Braun","year":"2021","unstructured":"Braun, A., Anders, H. J., Gudermann, T. & Mammadova-Bach, E. Platelet-cancer interplay: Molecular mechanisms and new therapeutic avenues. Front. Oncol. 12(11), 665534. https:\/\/doi.org\/10.3389\/fonc.2021.665534 (2021).","journal-title":"Front. Oncol."},{"issue":"14","key":"2104_CR60","doi-asserted-by":"publisher","first-page":"e34361","DOI":"10.1016\/j.heliyon.2024.e34361","volume":"10","author":"H Raskov","year":"2024","unstructured":"Raskov, H., Orhan, A., Agerb\u00e6k, M. \u00d8. & G\u00f6genur, I. The impact of platelets on the metastatic potential of tumour cells. Heliyon 10(14), e34361. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34361 (2024).","journal-title":"Heliyon"},{"key":"2104_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-44500-3_19","author":"GC Meneses","year":"2020","unstructured":"Meneses, G. C., de Lima Henn, G. A., Martins, A. M. C., Oliveira, M. J. C. & De Francesco Daher, E. Visceral leishmaniasis (Kala-azar) nephropathy. Trop. Nephrol. https:\/\/doi.org\/10.1007\/978-3-030-44500-3_19 (2020).","journal-title":"Trop. Nephrol."},{"key":"2104_CR62","doi-asserted-by":"publisher","DOI":"10.32768\/abc.202293346-353","author":"Y Tera","year":"2022","unstructured":"Tera, Y. et al. Platelet activation and platelet indices as markers for disease progression in women with breast cancer: Platelets and prognosis of breast cancer. Arch. Breast Cancer https:\/\/doi.org\/10.32768\/abc.202293346-353 (2022).","journal-title":"Arch. Breast Cancer"},{"issue":"6","key":"2104_CR63","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3109\/09537104.2012.711866","volume":"24","author":"M Kedzierska","year":"2013","unstructured":"Kedzierska, M. et al. The changes of blood platelet activation in breast cancer patients before surgery, after surgery, and in various phases of the chemotherapy. Platelets 24(6), 462\u2013468 (2013).","journal-title":"Platelets"},{"issue":"6","key":"2104_CR64","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.7314\/APJCP.2015.16.6.2409","volume":"16","author":"Y Okuturlar","year":"2015","unstructured":"Okuturlar, Y. et al. Utility of peripheral blood parameters in predicting breast cancer risk. Asian Pac. J. Cancer Prev. 16(6), 2409\u20132412 (2015).","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"6","key":"2104_CR65","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3324\/haematol.2021.279512","volume":"107","author":"DJ Kuter","year":"2022","unstructured":"Kuter, D. J. Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic malignancies. Haematologica 107(6), 1243\u20131263 (2022).","journal-title":"Haematologica"},{"key":"2104_CR66","unstructured":"Myelosuppression (Bone Marrow Suppression). (2023). Cleveland Clinic. https:\/\/my.clevelandclinic.org\/health\/diseases\/24788-myelosuppression?utm_source=chatgpt.com."},{"issue":"6","key":"2104_CR67","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.3892\/ol.2017.6054","volume":"13","author":"X Zhang","year":"2017","unstructured":"Zhang, X., Lv, Z., Yu, H. & Zhu, J. The clinicopathological and prognostic role of thrombocytosis in patients with cancer: A meta-analysis. Oncol. Lett. 13(6), 5002\u20135008. https:\/\/doi.org\/10.3892\/ol.2017.6054 (2017).","journal-title":"Oncol. Lett."},{"issue":"6","key":"2104_CR68","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.3892\/ol.2015.3784","volume":"10","author":"L Lian","year":"2015","unstructured":"Lian, L. et al. Mean platelet volume predicts chemotherapy response and prognosis in patients with unresectable gastric cancer. Oncol. Lett. 10(6), 3419\u20133424 (2015).","journal-title":"Oncol. Lett."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02104-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02104-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02104-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T21:02:46Z","timestamp":1747342966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02104-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2104"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-02104-w","relation":{"references":[{"id-type":"doi","id":"10.1042\/BSR20130057","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"23 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted after reviewed and approved by the ethical review committee of the School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar with (Reference No. SBMLS\/514). Moreover, letter of support was submitted to the UoG-CSH and FHCSH. Before starting the actual data collection, permission was obtained from both Hospitals Chief Executive Officer. Additionally, after explaining the purpose, benefits, and the possible risks of the study, written informed consent from the age of 18 and above and\/or assent from those less than 18\u00a0years old study participants along with written informed consent from their respective parents\/caregiver\/guardians was obtained. And also, written informed consent from illiterate study participants was obtained from their respective parents\/guardians. All laboratory results were kept confidential. Since those were stored in a file using codes without study participant\u2019s name. Apparently healthy participants, those positive for parasites, abnormal coagulation profiles, and platelet count were linked to the hospitals for appropriate treatment and management. All methods were carried out in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"16979"}}